Lemonade Dolls (LD) is the UK's first subscription underwear brand that aims to make hassle-free and comfortable underwear for young women. The company's revenue has grown 550% since January 2020. The Lemonade Dolls brand is sold in Topshop, New Look, and ASOS Marketplace. LD has 2,600 subscribers, 15,000 Dolls on its database, and over 70,000 followers across LD and Lemon's on Instagram. It also aims to bring audiences different brands like Candy Kittens, Frank Body, Dr Paw Paw, Mooncup, and Oh K!. The company has been praised by fashion magazine Grazia as having 'Broken the mould'. The company will use the investment to develop the technology behind its subscription platform, grow its product offering, strengthen its virtual presence, and drive brand awareness.
days to go:
Expired
investment:
£258,328
Equipsme is a company that aims to democratise health insurance by making it affordable for businesses. The company offers flexible fixed-price packages to employees while giving them the option to upgrade their package to avail more features upon payment. Members can speak to a general physician round the clock, have physiotherapy sessions, avail regular health checks and, if necessary, be quickly referred to a consultant for diagnosis and treatment. Members can access these features through a simple-to-use application. Since February 2018, the company has secured an exclusive 5-year insurance capacity deal with AXA PPP Healthcare and grown its members by 130.5% Year-on-Year (YoY) (to May 2020) with a 95% broker renewal retention rate. The company will use the investment to enhance its user experience and scale its marketing as it announces its partnerships with organisations such as Starling Bank and Simply Business.
days to go:
Expired
investment:
£879,204
Small Robot Company (SRC) aims to integrate its patented 'PerPlant' farming with agricultural practices worldwide and disrupt the $240 billion per year agriculture industry. SRC claims that PerPlant farming uses lightweight and smart robots that make food production more accurate, sustainable and profitable. SRC's three small robots, 'Tom', 'Dick' and 'Harry' coupled with AI brain 'Wilma' can plant, monitor and treat arable crops autonomously. SRC argues that it has successfully commercialised its PerPlant monitoring service for farmers in Wiltshire using its 'Tom V3' robots, built by leading robotics manufacturer, Tharsus. SRC stresses that it will equip its robots to kill weeds autonomously using electricity and perform trials with customers next season to demonstrate product readiness. SRC points out that it has raised more than £400,000 from willing farmers who want to embrace change. SRC has featured in WIRED, Economist and CNN. It has onboarded customers, including Waitrose and National Trust. SRC state they will use the investment to commercialise its patented R&D.
days to go:
Expired
investment:
£3,996,978
Solent Automation specialises in developing, deploying and supporting automation robots to perform and tackle common manual labour-intensive tasks in factories. To solve the 'pick-and-place' challenges in an industrial setup, these robots are created with proven reliable components coupled with proprietary software to solve 'pick-and-place' challenges in an industrial environment. Two of the company's noteworthy products are 'SOLPAL 8' and 'SOLPACK 1XP, both are equipped with an all-in-one gripping tool, and can handle 16 boxes per minute and 60 packs per minute, respectively. Backed by a team of experts from manufacturing and robotics, Solent Automation provides on-site installation, training, and remote support for its products. There is also a rent-to-buy option through a 3rd party finance company. With the investment, the company aims at providing more robotic equipment most needed in factories focused on labour-intensive work functions.
days to go:
Expired
investment:
£76,000
Span Health is a digital care platform that aims to help people avoid lifestyle-induced diseases, symptoms, medication, and complications. The company has helped more than 10,000 people to live a better and longer life. Span Health's easy-to-use mobile application allows patients to chat with clinicians, order blood tests at home, book video consultations, and see results in the application itself. Moreover, in 2019, the company agreed on a National Health Service (NHS) pilot test for 100 patients in collaboration with the National Institute of Health Research in North West London. Span Health will use the investment to provide employees with blood tests to screen for health risk factors and recover from detected illness safely and sustainably, improve its platform data insights, prediction and machine learning to better structure the clinician's processes, and further reduce its operational costs.
days to go:
Expired
investment:
£134,892
Fullgreen offers a range of 100% plant-based products that are low-carb and preservative-free alternatives for people looking to eat fewer carbohydrates, add more vegetables to their meals, or manage health issues such as obesity and diabetes. Fullgreen also claims that its products are shelf-stable negating the need to refrigerate. The company's catalogue includes non-Genetically Modified Organism (GMO) riced veggies, cauliflower risottos, and oat free plant-based breakfast meals, to name a few. Fullgreen points out that its products are listed in over 9,000 UK and US retailers. The company has dedicated production lines in the UK and US with a capacity of over 18 million pouches per annum. It has sold over 12 million pouches to date and earned £5.4 million in 2020. Fullgreen will use the investment to improve in-store promotions and activations, develop sampling activities for its target consumers, and boost geotargeted advertising and other digital marketing activities.
days to go:
Expired
investment:
£752,246
AndCo offers an open-source, cost-effective, sustainable solution to co-working by turning hotel lobbies and lavish eateries into co-working spaces all over London. The company has over 90 venues, over 1200 members and over 10 brand partnerships. It has been featured major publications including The Telegraph, Forbes, and The Metro. The funds raised will be used for marketing, development, hiring new teammates and working capital.
days to go:
Expired
investment:
£269,231
Equipsme is on a mission to democratise health insurance by making it affordable for businesses of all sizes. The company cites data arguing that there has been a 53% increase in National Health Service (NHS) treatment waiting lists since 2012 due to the low reach of health insurance by conventional insurance companies. It aims to change this scenario. Equipsme offers flexible fixed-price packages to companies wherein employees are allowed to upgrade and add family members to their plan as per their pleasure. Members can also speak to a General Physician (GP) 24/7, and, if necessary, be referred to a consultant for diagnosis and treatment through the company's proprietary app. The company was felicitated with the 'Best New Product' award by Cover Magazine Excellence Awards 2019. The company will use the investment to enhance its user experience, ensure its technology remains market-leading, and scale its marketing and customer service capability.
days to go:
Expired
investment:
£286,096
Pharmseal is a software company that aims to disrupt clinical trial management. The company claims that companies typically use multiple applications for managing clinical trials from one or more vendors. This increases cost and complexity. Pharmaseal asserts that its cloud Business-2-Business (B2B) platform, Engility, simplifies control by providing a single management portal. The platform allows information to be centralised and accessed from a single platform. Pharmaseal claims that Engility will allow companies to save cost and time and enable them to bring life-saving drugs to market faster. The company will utilise 31% of the investment for commercialisation and marketing, 49% for product development, 13% for IT infrastructure, and 7% for administrative/legal/miscellaneous activities.
days to go:
Expired
investment:
£532,311
Skin In Motion (SIM) is a first-of-its-kind exercise-friendly beauty range that seeks to promote the positive effects of exercise through healthy and confidence-boosting skincare and makeup products specifically designed to be worn pre, during, and post-exercise. SIM claims that its products are available Direct To Consumer (DTC) via its website and are listed on LookFantastic, Amazon and Oliver Bonas. SIM was awarded the 'Best New Business 2020' award by the Women's Business Club. The brand has reached 3 million potential customers and has an Instagram following of 3,000 to date. The company has also featured in Sunday Times Style Magazine, Hello!, RED Magazine, and Women's Health, to name a few. It will use the investment to grow its team, increase marketing and brand awareness, and accelerate new product developments.
days to go:
Expired
investment:
£166,111
